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Background/Objectives: Although total body skin examination (TBSE) is the primary screening 
mechanism for melanoma, there is no consensus on which anatomic sites a screening TBSE should 
include. We sought to establish which anatomic sites are examined during routine (>90%) TBSEs of 
patients at high risk for skin cancer.
Methods: A Google survey was emailed to 173 international dermatologist skin cancer specialists.
Results: More than 75% of participants reported routinely examining the scalp, ears, face and neck, 
trunk, breasts, inframammary areas, axillae, extremities, palms and soles, nails, interdigital spaces, and 
buttocks. The least frequently inspected anatomic sites included genitalia, with male genitalia more 
frequently examined than female (penis n = 39; 52%; labia majora n = 21; 28%; P = 0.003), the peri-
anal region (n = 26; 34.7%), and the ocular conjunctiva and oral mucosa (n = 35; 46.7%). Participants 
cited not screening these areas because of perceived patient discomfort, low prevalence of malignancy, 
and the expectation that other specialists examine the area.
Conclusions: The role of routine surveillance of neglected anatomic sites is unclear and warrants 
further discussion weighing potential mortality benefit against the incidence of melanoma in obscure 
sites, morbidity of intervention in sensitive sites, cost-effectiveness, and potential for patient discom-
fort.
ABSTRACT
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national Dermoscopy Society (IDS), (2) the United States 
Pigmented Lesion Clinic Group, and (3) the Skin Cancer 
Foundation. Email addresses were collected using the IDS 
website in conjunction with the American Academy of Der-
matology directory.
Survey Administration
The study was approved by the Memorial Sloan Ketter-
ing Cancer Center Institutional Review Board without the 
requirement for written informed consent in accordance 
with the Helsinki Declaration. Participation in the survey 
study was voluntary; therefore, completion of the survey was 
considered to be tacit consent. No identifying information on 
participants was collected (eg, name, email). The survey was 
hosted on Google survey, and a link to the survey was emailed 
to all participants. Participants were contacted 3 times: an 
initial email in September 2016 and 2 follow-up emails, the 
first in October 2016 and the second in December 2016. The 
survey was closed to participants at the end of January 2017.
The survey was designed to capture only the responses of 
dermatologists who participated in the care of high-risk skin 
cancer patients. If a participant answered that their practice 
did not meet this criterion, the survey automatically ended 
and their responses were not included. Furthermore, all 
questions were worded specifically to target the dermatolo-
gist’s clinic dedicated to the care of high-risk patients. The 
survey instrument can be found in the online supplemen-
tary material.
Statistical Analysis
Descriptive and relative frequencies along with cross-clas-
sifications were used to describe the survey responses. To 
reduce the potential for type 1 errors based on multiple 
comparisons, we used the Bonferroni correction and divided 
the study α-level by the number of comparisons made α/20 ~= 
0.002. Proportions were considered statistically different at 
an α-level of <0.002.
Results
Seventy-seven of the 173 (44.5%) participants in the target 
sample completed the survey. Analysis was subsequently per-
formed on 75 of the original 77 participants, as 1 respondent 
stated their clinic did not have a portion of care dedicated to 
the care of patients at high risk for skin cancer, and 1 respon-
dent was excluded, as he/she was a nurse practitioner and 
not a practicing dermatologist. Table 1 displays demograph-
ics and baseline practices of survey respondents. Of the 75 
participants, 43 (57.3%) were male, 35 (46.7%) were from 
the USA, and 36 (48%) recorded practicing in countries in 
Europe, South America, Asia, and Australia. A majority of 
Introduction
Skin cancer is the most common human malignancy, with 
more than 5 million cases diagnosed in the United States 
annually [1]. The visible nature of cutaneous malignancies 
presents a theoretical opportunity for secondary prevention 
of disease not possible for many other malignancies. Stud-
ies have shown that receiving a screening total body skin 
examination (TBSE) independently increases the likelihood 
of identifying melanoma and reduces the incidence of thick 
melanomas. Furthermore, detection of early melanoma results 
in more treatable disease and better prognosis, with 5-year 
survival of thin melanoma nearing 99% [2,3]. However, skin 
cancer screening, even in the highest risk populations, is con-
troversial, as no prospective randomized controlled trial has 
been conducted that shows demonstrable mortality benefit. 
Though controversial, screening TBSEs by dermatologists 
present the critical potential for dermatologists to detect 
early disease.
Although most dermatologists recognize the important 
role for TBSEs and its teaching is incorporated as a funda-
mental in postgraduate dermatology education, there has 
been little published with regard to what anatomic sites 
should reproducibly constitute a TBSE. While textbooks sug-
gest in-depth, thorough screening of the total body including 
obscure anatomic sites, there is no accepted standard within 
the dermatologic community of which sites are routinely 
examined in practice, and moreover no consensus of which 
sites should be routinely examined. The authors’ anecdotal 
evidence suggests that inspection of certain obscure anatomic 
sites including genitalia, intergluteal clefts, perianal areas, and 
oral and ocular mucosa is not always performed on routine 
TBSEs because of perceived patient embarrassment, low 
prevalence of malignancy, and the perception that particu-
lar anatomic sites are likely examined by other specialists. 
The rationale for our study was therefore to begin to better 
understand baseline TBSE practices, by first studying the 
practices of dermatologist skin cancer specialists. The primary 
objective of our study was to identify which anatomic sites 
are routinely examined during TBSEs (>90% of the time) in 
patients at high risk for skin cancer. The secondary objective 
was to identify the rationale for not examining particular 
anatomic sites. We hypothesized that obscure anatomic sites 
are likely infrequently examined during TBSEs even amongst 
dermatologist skin cancer specialists.
Methods
Participants
The contact information for 173 international dermatolo-
gists deemed skin cancer specialists was compiled from (1) 
board members and executive board members of the Inter-
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Table 2 presents the frequency by which survey respon-
dents reported routinely examining each anatomic site. 
Greater than 75% of participants reported routinely exam-
ining the following areas during TBSEs: scalp, ears, face and 
neck, trunk, breasts, inframammary areas, axillae, extremities, 
palms and soles, finger and toenails, interdigital spaces, and 
buttocks. The scalp was reported to be routinely examined by 
84% of participants (n = 63). Of those who do not examine 
the scalp, the primary reason cited was low prevalence of 
malignancy. The ocular conjunctiva and oral mucosa were 
routinely examined by fewer than half of participants (n = 
35; 46.7%). The main reasons for not examining these sites 
included the expectation that other specialists examine these 
areas and low prevalence of malignancy, which is depicted in 
graphical form in Figure 1.
The perianal region (n = 26; 34.7%), labia majora (n = 21; 
28%), and labia minora (n = 8; n = 10.7%) were infrequently 
examined. Survey respondents reported routinely screening 
the scrotum (n = 38; 50.7%) and penis (n = 39; 52%) more 
often than the female genitalia. The vagina was examined 
participants (n = 47; 62.7%) had >40% of their clinic devoted 
to the care of high-risk skin cancer patients.
A majority of survey respondents reported always using 
dermoscopy for TBSEs (n = 64; 85.3%). Three respondents 
reported never using dermoscopy for TBSEs. While 20 par-
ticipants (26.7%) reported using total body photography 
for comparison during TBSEs in >40% of their high-risk 
patients, 60 (80%) reported that their examination rooms 
were equipped with monitors for viewing baseline photos 
and/or digital dermoscopy. Nearly all participants (n = 69; 
92%) stated their examination rooms were equipped with 
good overhead lighting, while a minority reported their 
examination rooms were equipped with stirrups, vaginal 
specula, and hair dryers for the inspection of scalp lesions (n 
= 16, 21.3%; n = 5, 6.7%; n = 1, 1.3%, respectively).
In preparation for the TBSE, the majority of dermatolo-
gists surveyed (n = 44; 58.7%) stated patents are always told 
to remove all their clothing, including undergarments, and 
the majority of high-risk patients comply >60% of the time 
(n = 51; 68%).
Sex
 Female 31 (41.3%)
Country of practice
 Asia 4/73 (5.5%)
 Australia  2/73 (2.7%)
 Europe 26/73 (35.6%)
 North America 37/73 (50.7%)
 South America 4/73 (5.5%)
Median years practicing post-residency 20 yrs
Percentage of clinic dedicated to care of high-risk patients
 1%-20% 11/75 (14.7%)
 21%-40% 17/75 (22.7%)
 41%-60% 16/75 (21.3%)
 61%-80% 10/75 (13.3%)
 81%-100% 21/75 (28%)
Time to perform TBSE
 0-10 minutes 51/75 (68%)
 10+ minutes 24/75 (32%)
Time allocated for new visit
 0-20 minutes 32/74 (43.2%)
 21-30 minutes 27/74 (36.5%)
 30+ minutes 15/74 (20.3%)
Time allocated for follow-up visit
 0-20 minutes 49/73 (67.1%)
 21-30 minutes 17/73 (23.3%)
 30+ minutes 7/73 (9.6%)
Do you/office staff ask patients to disrobe including 
undergarments (ie, underpants and/or bra)?
 Always 44/75 (58.7%)
 Sometimes 24/75 (32%)
 Never 7/75 (9.3%)
For those who ask their patients, how often do patients 
comply?
 0%-40% 6/68 (8.8%)
 41%-80% 26/68 (38.2%)
 81%-100% 36/68 (52.9%)
Equipment in room
 Good overhead lighting 69/75 (92%)
 Auxiliary lighting 49/75 (65.3%)
 Monitors for viewing photos/digital 
dermoscopy
60/75 (80%)
 Stirrups 16/75 (21.3%)
 Vaginal specula 5/75 (6.7%)
 Hair dryer 1/75 (1.3%)
Positions in which patients are examined
 Sitting 2/75 (2.7%)
 Standing 9/75 (12%)
 Lying 22/75 (29.3%)
 Two of the above positions 13/75 (17.3%)
 All 3 (sitting, standing, and lying) 26/75 (34.7%)
Table 1. Demographics and Baseline Practices of Survey Respondents (N = 75)
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screening patients at high risk for skin cancer reported not 
routinely examining the genitalia, perianal area, oral mucosa, 
and ocular conjunctiva. We hope that our findings stimulate 
thought-provoking debate within the dermatology commu-
nity about whether these sites should be routinely examined 
during screening TBSEs.
Within the medical community there is growing recogni-
tion of the harms posed by broad-stroked, intuition-based 
cancer screening where there has been no demonstrable effect 
on mortality [6]. For melanoma, there is no doubt that finding 
early-stage localized thin disease reduces mortality [7]. The 
5-year melanoma-specific survival for mucosal melanoma 
is in staunch contrast to that of cutaneous melanoma, 61% 
vs 91%, respectively. This raises the inevitable question of 
whether increased screening of such neglected sites would 
improve prognosis by identifying early-stage disease. How-
ever, before recommending nuanced screening for specific 
target populations, such as for acral lentiginous melanoma 
least frequently (n = 2; 2.7%). The primary reason cited for 
not examining the male/female genitalia included patient 
discomfort (n = 27/59; 45.7%), with a similar number of 
participants citing that other specialists examine this area 
(n = 24/59; 40.7%) and a few also citing low prevalence of 
malignancy (n = 8/59; 13.6%).
Discussion
To our knowledge, our study is the first to delve deeply into 
the practices of dermatologists when performing TBSEs, 
including the content, technique, and rationale. In reviewing 
the literature pertaining to screening TBSEs, only a few stud-
ies explicitly state in their methodology which anatomic sites 
were screened during TBSEs, and when detailed, anatomic 
sites examined were not standardized among different stud-
ies [3-5]. Our international survey study showed that both in 
the United States and abroad, the majority of dermatologists 
Table 2. Frequency of Survey Respondents Examining Each Anatomic Location
Anatomic Location
% of Survey Respondents  
Who Reported Routinely  
Examining Site, % (n)
P Valuea,b
Scalp* 84% (63/75) 0.001
Ears 94.7% (71/75) 0.17
Face and neck 98.7% (74/75) 1
Ocular conjunctiva* 46.7% (35/75) <0.00001
Oral mucosa* 46.7% (35/75) <0.00001
Trunk (abdomen, chest, and back) 98.7% (74/75)    –
Breast 93.3% (70/75) 0.09
Inframammary areas 96% (72/75) 0.31
Axillae 93.3% (70/75) 0.09
Extremities 98.7% (74/75) 1
Palms and soles 97.3% (73/75) 0.56
Interdigital spaces 85.3% (64/75) 0.002
Fingernails 96% (72/75) 0.31
Toenails 96% (72/75) 0.31
Scrotum* 50.7% (38/75) <0.00001
Penis* 52% (39/75) <0.00001
Labia majora* 28% (21/75) <0.00001
Labia minora* 10.7% (8/75) <0.00001
Vagina* 2.7% (2/75) <0.00001
Buttocks 93.3% (70/75) 0.09
Intergluteal cleft* 70.7% (53/75) <0.00001
Perianal region* 34.7% (26/75) <0.00001
aP value comparing likelihood of examining site vs not examining site using trunk (abdomen/chest/back) 
as reference; calculated using chi-square test.
bTo account for multiple comparisons, a P value of <0.002 was considered significantly different.
*Statistically significant result.
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melanoma (including the nasal cavity, accessory sinuses, oral 
cavity, anorectal area, genital tract) was approximately 2 
per 1 million [12]. This low incidence is disproportionate 
when compared to our tendency to over-biopsy; as one study 
found, more than 1,000 benign nevi were biopsied between 
2009 and 2013 in order to detect 1 melanoma in patients 
under 19 years of age [13]. The low incidence of melanoma 
in these sites, when contextualized with both the expected 
morbidity from increased screening and with the already high 
biopsy rate, raises important questions regarding surveillance 
recommendations.
In addition to citing low prevalence of malignancy as 
rationale for not examining oral mucosa, ocular mucosa, and 
genitalia, many dermatologists in our study also reported that 
they avoided examination of the genitalia because of patient 
discomfort. Perceived patient discomfort with examination 
of sensitive areas may be exacerbated when the gender of 
the physician differs from that of the patient as studies have 
corroborated for pelvic examinations, colonoscopies, and 
even most recently for TBSEs that female patients have a 
preference toward female physicians [14-16]. Significantly, 
studies have shown that patients who were educated on the 
importance of TBSEs were found to have decreased discom-
fort when receiving a genital examination [17].
Perhaps a more effective method for surveillance of such 
anatomic sites lies in empowering patients to be vigilant in 
their own skin self-examination. In one study of patients with 
in dark-skinned populations, or in this case for increased 
screening of neglected anatomic sites, we caution readers to 
consider the potential harms of increased surveillance [8,9].
To date there is no evidence that surveillance of obscure 
anatomic sites would result in decreased mortality from 
melanoma. Mucosal melanoma, as compared to cutaneous 
melanoma, has a unique mutation signature, distinct patho-
genesis, and may be an independently more aggressive disease 
process. Furthermore, increased surveillance would likely 
result in an increased number of surgical procedures and 
increased morbidity. When considering the atypical clinical, 
dermoscopic, and histopathological spectrum surrounding 
“nevi of special sites,” the expected morbidity and rate of 
excess surgical intervention would be exacerbated in the 
genital and perianal sites in specific [10]. As such, clinicians 
examining these areas must be aware of the degree of clinical 
atypia present in even benign melanosis [11]. With sensitive 
anatomic sites, we could expect both functional and cosmetic 
impairment from repetitive intervention. Such interventions 
are equally fraught with patient anxiety.
It is equally our burden to weigh the surmounting health 
care costs associated with increased procedures against the 
exceedingly low incidence of melanoma in the anatomic 
sites that our study suggests are infrequently being exam-
ined, even in patients at the highest risk for skin cancer. In 
2010, statistics from the Surveillance, Epidemiology, End 
Results Program database showed the incidence for mucosal 
Figure 1. Rationale for not examining particular anatomic sites. [Copyright: ©2019 Bajaj et al.]
Research  |  Dermatol Pract Concept 2019;9(2):9 137
Conclusions
Our study sheds insight into the screening habits of skin can-
cer specialists when performing routine TBSEs on patients at 
high risk for skin cancer. Overall, we found that the genitalia, 
perianal regions, ocular conjunctiva, and oral mucosa are not 
routinely examined with the rationale that these anatomic 
sites are associated with a low prevalence of malignancy and 
that other experts examine these sites. Further studies that 
investigate the morbidity, cost-effectiveness, patient prefer-
ence, and potential mortality benefit of examining particular 
anatomic sites will help to establish what a routine TBSE 
should include.
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